Related Experiment Video
Updated: Jul 4, 2025

Author Spotlight: Exploring Mitochondrial Function and Chemical Toxicity Using Drosophila melanogaster
Published on: November 10, 2023
A Drosophila model of mitochondrial disease phenotypic heterogeneity
Lucy Granat1, Debbra Y Knorr1, Daniel C Ranson1
1Maurice Wohl Clinical Neuroscience Institute, King's College London, 5 Cutcombe Road, London SE5 9RX, UK.
Abstract:
Mutations in genes that affect mitochondrial function cause primary mitochondrial diseases. Mitochondrial diseases are highly heterogeneous and even patients with the same mitochondrial disease can exhibit broad phenotypic heterogeneity, which is poorly understood. Mutations in subunits of mitochondrial respiratory complex I cause complex I deficiency, which can result in severe neurological symptoms and death in infancy. However, some complex I deficiency patients present with much milder symptoms. The most common nuclear gene mutated in complex I deficiency is the highly conserved core subunit NDUFS1. To model the phenotypic heterogeneity in complex I deficiency, we used RNAi lines targeting the Drosophila NDUFS1 homolog ND-75 with different efficiencies. Strong knockdown of ND-75 in Drosophila neurons resulted in severe behavioural phenotypes, reduced lifespan, altered mitochondrial morphology, reduced endoplasmic reticulum (ER)-mitochondria contacts and activation of the unfolded protein response (UPR). By contrast, weak ND-75 knockdown caused much milder behavioural phenotypes and changes in mitochondrial morphology. Moreover, weak ND-75 did not alter ER-mitochondria contacts or activate the UPR. Weak and strong ND-75 knockdown resulted in overlapping but distinct transcriptional responses in the brain, with weak knockdown specifically affecting proteosome activity and immune response genes. Metabolism was also differentially affected by weak and strong ND-75 knockdown including gamma-aminobutyric acid (GABA) levels, which may contribute to neuronal dysfunction in ND-75 knockdown flies. Several metabolic processes were only affected by strong ND-75 knockdown including the pentose phosphate pathway and the metabolite 2-hydroxyglutarate (2-HG), suggesting 2-HG as a candidate biomarker of severe neurological mitochondrial disease. Thus, our Drosophila model provides the means to dissect the mechanisms underlying phenotypic heterogeneity in mitochondrial disease.
Insights
Investigating complex I deficiency, this study used Drosophila to model disease heterogeneity. Different knockdown levels of ND-75 revealed distinct effects on behavior, metabolism, and gene expression, offering insights into mitochondrial disease variability.
Area of Science:
- Neuroscience
- Genetics
- Cell Biology
Background:
- Primary mitochondrial diseases stem from genetic mutations affecting mitochondrial function.
- Complex I deficiency, caused by mutations in NDUFS1, presents with variable neurological symptoms and severity.
- Phenotypic heterogeneity in mitochondrial diseases remains poorly understood.
Purpose of the Study:
- To model the phenotypic heterogeneity of complex I deficiency using a Drosophila model.
- To investigate the molecular and metabolic mechanisms underlying differential disease severity.
Main Methods:
- Utilized RNAi targeting the Drosophila NDUFS1 homolog, ND-75, with varying efficiencies in neurons.
- Assessed behavioral phenotypes, lifespan, mitochondrial morphology, ER-mitochondria contacts, and unfolded protein response (UPR).
- Analyzed transcriptional responses and metabolic profiles, including neurotransmitter levels and specific metabolites.
Main Results:
- Strong ND-75 knockdown caused severe phenotypes, altered mitochondrial and ER-mitochondria morphology, and UPR activation.
- Weak ND-75 knockdown resulted in milder phenotypes with distinct transcriptional and metabolic alterations, affecting proteasome and immune genes.
- Metabolic changes, including GABA levels, differed between strong and weak knockdown; 2-hydroxyglutarate (2-HG) was elevated only in strong knockdown.
Conclusions:
- Drosophila ND-75 knockdown effectively models complex I deficiency heterogeneity.
- Differential gene expression and metabolic shifts contribute to varying disease severity.
- 2-HG emerges as a potential biomarker for severe neurological mitochondrial disease.
Related Concept Videos
Incomplete Dominance
Animal Mitochondrial Genetics

